CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia
Summary
GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Colombia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the Colombia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
The Colombian healthcare market has significant potential for growth. The extensive health insurance system and presence of Free Trade Agreement (FTA) with the US are the main drivers for growth. The pharmaceutical value for Colombia in 2011 was $2.66B and declined to $1.71B in 2016 at negative CAGR of 8.5%.The pharmaceutical market is expected to reach $1.45B in 2022. The medical devices market in Colombia is mainly import-based. Colombia offers affordable private healthcare with better quality.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the Colombia, and includes -
- An overview of the pharmaceutical markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Roche, Pfizer, Merck, Procaps and Sanofi)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Colombia
- Information regarding the health-tech landscape of the country along with the major health-tech deals
- Porter’s five forces analysis for pharmaceutical market of Colombia
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities and challenges to growth in the Colombia healthcare market
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Colombia healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Colombia healthcare market
- Executive Summary
- Overview of Pharmaceutical Market
- Deals Analysis
- HealthTech Landscape
- Porter’s Five Forces Analysis
- Market Access
- Country Healthcare Landscape
- Opportunities and Challenges
- Appendix
- List of Tables
- Table 1: Market Authorization Fees, Colombia, 2019
- Table 2: Classification of Medical Device, Colombia
- Table 3: Premarket Approval Process
- Table 4: Patent Fees, Colombia, 2019
- Table 5: Packaging Requirements, Colombia, 2018
- Table 6: Trade Fair, Colombia
- List of Figures
- Figure 1: Pharmaceutical Market, Colombia, Revenue, 2011-2016
- Figure 2: Pharmaceutical Market, Colombia, Revenue, 2017-2022
- Figure 3: Healthcare Start-Ups in Colombia, 2019
- Figure 4: Number of Deals (2017-2018)
- Figure 5: 2017-2018 Deal Overview By Region
- Figure 6: Country Profile, Colombia, 2018
- Figure 7: Pharmaceutical Market, Colombia, Revenue, 2011-2016
- Figure 8: Pharmaceutical Market, Colombia, Revenue Forecast, 2017-2022
- Figure 9: Pharmaceutical Market, Colombia, Pharmaceutical Exports, 2018
- Figure 10: Pharmaceutical Market, Colombia, Top Export Partners, 2018
- Figure 11: Pharmaceutical Market, Colombia, Pharmaceutical Imports, 2018
- Figure 12: Pharmaceutical Market, Colombia, Top Import Partners, 2018
- Figure 13: Pharmaceutical Market, Pharmaceutical Supply Channel, Colombia, 2018
- Figure 14: Pharmaceutical Market, OTC Market, Colombia, Revenue ($M), 2010-2018
- Figure 15: Pharmaceutical Market, OTC Product Group Sales ($M), Colombia, 2018
- Figure 16: Pharmaceutical Market, Colombia, Major Players
- Figure 17:Deal Value and Deal Count, Pharmaceutical Market, Colombia, 2018-2019
- Figure 18: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Colombia, 2018-2019
- Figure 19: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Colombia, 2018-2019
- Figure 20: Deal Value($M) , HealthTech, Colombia, 2018-2019
- Figure 21: Deal Count, HealthTech, Colombia, 2018-2019
- Figure 22: Adoption of Technology in Healthcare, Colombia, 2019
- Figure 23: Market Access, Overview of Healthcare System, Colombia, 2019
- Figure 24: Market Access, OOP Expenditure (% of Total Expenditure on Health), Colombia
- Figure 25: Market Access, Annual Average Rates of Price Change (%), Consumer Price Index, Colombia, 2014-2018
- Figure 26: Market Access, SISMED Monitoring Process, Colombia, 2018
- Figure 27: Market Access, Structure of INVIMA, Colombia, 2018
- Figure 28: Market Access, Registration Process for New Drugs, 2019
- Figure 29: Market Access, Regulatory Landscape, Generic Drug Approval Process, Colombia, 2018
- Figure 30: Medical Device (Class I, IIa, IIb, III) Registration Requirements, Colombia
- Figure 31: Medical Device (Class I, IIa, IIb, III) Registration Requirements, Colombia
- Figure 32: Licensing Process for Manufacturing, Colombia, 2018
- Figure 33: Patent Approval Process, Colombia, 2018
- Figure 34: Pharmaceutical Clinical Trials Count By Trial Status, Colombia, 2018-2019
- Figure 35: Pharmaceutical Clinical Trials Count By Phase, Colombia, 2018-2019
- Figure 36: Pharmaceutical Clinical Trials Count By Therapy Area, Colombia, 2018-2019
- Figure 37: Pharmaceutical Clinical Trials Site, Colombia, 2018-2019
- Figure 38: Colombia Healthcare Policy Highlights, Colombia, 2019
- Figure 39: Hospital Beds (per 1,000 Population), Colombia, 2010-2018
- Figure 40: Diagnostic Equipment (per million population), Colombia, 2011-2018
- Figure 41: Life Expectancy, 2010-2018, Colombia
- Figure 42: Immunization Rate (%), 2010-2018, Colombia
- Figure 43: PM2.5 (µg per m3), Colombia, 2010-2018
- Figure 44: CO2 Emissions (Million Tons), Colombia, 2010-2018
- Figure 45: Physicians (per 1,000 Population), Colombia, 2011-2018
- Figure 46: Nurses (per 1,000 Population), Colombia, 2011-2018
- Figure 47: Dentists (per 1,000 Population), Colombia, 2011-2018
- Figure 48: Major Causes of Mortality (per 1,000 Population), Colombia, 2016
- Figure 49: Major Causes of Male Mortality, Colombia, 2016
- Figure 50: Major Causes of Female Mortality, Colombia, 2016
- Figure 51: Disability-Adjusted Life Years by Major Disease (‘000), Colombia, 2016
- Figure 52: Healthcare Expenditure as Percentage of GDP (%), Colombia, 2011-2018
- Figure 53: Public-Private Share (%), Colombia, 2011-2018
- Figure 54: Opportunities and Challenges, Colombia
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook